- Assier H, Bastuji-Garin S, Revuz J, et al. Erythema multiforme with mucous membrane involvement
and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol
1995; 131(5):539–543. - Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis,
Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129(1):92–96. - Hayes EB, Komar N, Nasci RS, et al. Epidemiology and transmission dynamics of West Nile Virus
disease. Emerg Infect Dis 2005; 11(8):1167–1173. - Centers for Disease Control and Prevention (CDC). West Nile virus activity—United States, 2007.
MMWR Morb Mortal Wkly Rep 2008; 57(26):720–723. - O’Leary DR, Marfin AA, Montgomery SP, et al. The epidemic of West Nile virus in the United States,
2002. Vector Borne Zoonotic Dis 2004; 4(1):61–70. - Petersen LR, Hayes EB. Westward ho?—The spread of West Nile virus. N Engl J Med 2004;
351(22):2257–2259. - Zeller HG, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the
Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis 2004;
23(3):147–156. - Hayes EB, O’Leary DR. West Nile virus infection: a pediatric perspective. Pediatrics 2004; 113(5):
1375–1381. - Kumar D, Prasad GV, Zaltzman J, et al. Community-acquired West Nile virus infection in solid-
organ transplant recipients. Transplantation 2004; 77(3):399–402. - Stramer SL, Fang CT, Foster GA, et al. West Nile virus among blood donors in the United States,
2003 and 2004. N Engl J Med 2005; 353(5):451–459. - Diamond MS, Shrestha B, Mehlhop E, et al. Innate and adaptive immune responses determine
protection against disseminated infection by West Nile encephalitis virus. Viral Immunol 2003; 16(3):
259–278. - Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999:
results of a household-based seroepidemiological survey. Lancet 2001; 358(9278):261–264. - Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile
fever. Ann Intern Med 2004; 141(5):360–365. - Hayes EB, Sejvar JJ, Zaki SR, et al. Virology, pathology, and clinical manifestations of West Nile
Virus. Emerg Infect Dis 2005; 11(8):1174–1179. - Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: morbidity and mortality
among patients admitted to hospital in south-central Ontario. CMAJ 2003; 168(11):1399–1405. - Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus
infection. JAMA 2003; 290(4):511–515. - Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis
2005; 11(7):1021–1027. - Tilley PA, Zachary GA, Walle R, et al. West Nile virus detection and commercial assays. Emerg
Infect Dis 2005; 11(7):1154–1155. - Martin DA, Biggerstaff BJ, Allen B, et al. Use of immunoglobulin M cross-reactions in differential
diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol
2002; 9(3):544–549. - Reich HL, Crawford GH, Pelle MT, et al. Group B streptococcal toxic shock-like syndrome. Arch
Dermatol 2004; 140(2):163–166. - Todd J, Fishaut M, Kapral F, et al. Toxic-shock syndrome associated with phage-group-I
Staphylococci. Lancet 1978; 2(8100):1116–1118. - Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a
toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321(1):1–7. - Hajjeh RA, Reingold A, Weil A, et al. Toxic shock syndrome in the United States: surveillance
update, 1979-1996. Emerg Infect Dis 1999; 5(6):807–810. - Reduced incidence of menstrual toxic-shock syndrome—United States, 1980–1990. MMWR Morb
Mortal Wkly Rep 1990; 39(25):421–423. - Bergdoll MS, Crass BA, Reiser RF et al. A new staphylococcal enterotoxin, enterotoxin F, associated
with toxic-shock-syndromeStaphylococcus aureusisolates. Lancet 1981; 1(8228):1017–1021. - Schlievert PM. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly
associated with non-menstrual TSS. Lancet 1986; 1(8490):1149–1150. - Schlievert PM, Shands KN, Dan BB, et al. Identification and characterization of an exotoxin from
Staphylococcus aureusassociated with toxic-shock syndrome. J Infect Dis 1981; 143(4):509–516. - Lee VT, Chang AH, Chow AW. Detection of staphylococcal enterotoxin B among toxic shock syndrome
(TSS)- and non-TSS-associatedStaphylococcus aureusisolates. J Infect Dis 1992; 166(4):911–915.
44 Engel et al.